357.27
Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-27 | 2025-06-28 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.83%
1,004.08
|
995.83 | 994.23 | 1,004.85 | 1,032.13 |
| Selling, General, and Administrative |
43.58%
228.90
|
159.42 | - | - | - |
| Operating Income/Loss |
0.01%
119.89
|
119.90 | -283.44 | 133.80 | 100.13 |
| Income Tax Expense/Benefit |
456.21%
53.93
|
-15.14 | -17.81 | 31.64 | 18.73 |
| Net Income/Loss |
94.87%
-0.76
|
-14.80 | -276.29 | 55.56 | 52.69 |
| Attributable To Noncontrolling Interest |
1,661%
0.722
|
0.041 | 0.265 | 1.134 | 0.367 |
| Basic Average Shares |
1.90%
48.02
|
48.95 | -0.116 | 49.21 | 49.15 |
| Diluted Average Shares |
1.90%
48.02
|
48.95 | -0.302 | 49.43 | 49.32 |
| Basic Earnings Per Share |
90.00%
-0.03
|
-0.30 | -5.57 | 1.11 | 1.06 |
| Diluted Earnings Per Share |
90.00%
-0.03
|
-0.30 | -5.56 | 1.10 | 1.06 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):